Sigma Planning Corp’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,187
Closed -$340K 961
2023
Q3
$340K Buy
+15,187
New +$367K 0.01% 871
2020
Q1
Sell
-8,404
Closed -$292K 980
2019
Q4
$292K Sell
8,404
-9,169
-52% -$310K 0.01% 815
2019
Q3
$567K Sell
17,573
-91,269
-84% -$3.12M 0.03% 537
2019
Q2
$3.73M Buy
108,842
+60,104
+123% +$2.03M 0.19% 131
2019
Q1
$1.63M Sell
48,738
-12,734
-21% -$401K 0.09% 232
2018
Q4
$1.7M Sell
61,472
-775
-1% -$24K 0.12% 176
2018
Q3
$2.39M Buy
62,247
+30,215
+94% +$1.11M 0.14% 158
2018
Q2
$1.12M Buy
32,032
+13,025
+69% +$454K 0.08% 256
2018
Q1
$633K Buy
+19,007
New +$647K 0.05% 372

Other funds holding FFTY

Sigma Planning Corp's FFTY Position: Q4 2023 in Review

Sigma Planning Corp sold out of CapForce IBD 50 ETF (FFTY) in Q4 2023, closing a stake of 15,187 shares — an estimated $340K sold.

Sigma Planning Corp first reported a position in FFTY in Q1 2018 and held it in 9 quarters. The position peaked at $3.73M in Q2 2019. 40 funds tracked by Wall St. Rank hold FFTY as of Q4 2023.

  • Sigma Planning Corp reported no remaining CapForce IBD 50 ETF position as of Q4 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 15,187 CapForce IBD 50 ETF shares in Q4 2023, an estimated $340K.
  • Sigma Planning Corp first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 9 quarters.
  • Sigma Planning Corp's CapForce IBD 50 ETF position peaked at $3.73M in Q2 2019.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2023.

Based on Sigma Planning Corp's 13F filing for Q4 2023, filed 1 Feb 2024.